News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
Honoring the many lived experiences with Long COVID
RECOVER recognizes International Long COVID Awareness Day on March 15—a day established by the Long COVID community to increase visibility of the condition, share resources, and educate the public.
Feature
20 Results
20 Results
RECOVER Research Update: March 2026
Recent RECOVER publications include findings about possible causes of and treatments for Long COVID.
Feature
5 years in, RECOVER continues to advance its patient-centered mission
RECOVER marks 5 years of Long COVID research, with NIH leaders, scientists, and clinicians continuing to guide and advance the initiative’s mission. In 2026, RECOVER will expand clinical trials to find answers for the Long COVID community.
News Release
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
Over 1.4 million biosamples available in RECOVER’s biorepository to support Long COVID research
Biostatisticians and clinicians work together to help funded study teams access resources stored in RECOVER’s biorepository, a unique collection of biosamples from almost 30,000 adults and children.
Feature
RECOVER biosamples and data advance understanding of what may cause Long COVID
RECOVER pathobiologists have designed a large, collaborative, and innovative study that can help to develop diagnostics for specific types of Long COVID.
Feature
Registration open for second annual RECOVER-TLC workshop, September 9-10
NIH leaders and RECOVER researchers will provide updates on RECOVER-Treating Long COVID (RECOVER-TLC), the next phase of RECOVER Long COVID clinical trials.
Announcement
Researchers invited to submit proposals for new round of ancillary pathobiology studies
RECOVER released a call for ancillary pathobiology study proposals that will build on the more than 60 existing funded studies and will address unanswered questions about Long COVID.
Feature
RECOVER’s mid-year milestones: A look at 2025 progress
This year, RECOVER researchers continue to publish results from research studies that deepen our understanding of Long COVID. RECOVER studies continue, with 2 clinical trials expected to reach enrollment goals this summer.
Feature